Letters sent to healthcare professionals in March 2018

Letters were sent to healthcare professionals about Zinbryta鈻� (daclizumab beta), Lynparza 50 mg capsules, and radium-223-dichloride (Xofigo鈻�).

From:
Medicines and Healthcare products Regulatory Agency
Published
24 April 2018
Therapeutic area:
Cancer, Haematology and oncology and Neurology

In March 2018, letters were sent to healthcare professionals about:

Article citation: Drug Safety Update volume 11 issue 9; April 2018: 4.

Updates to this page

Published 24 April 2018

Related content